Narcolepsy and COVID19
COVID-19 is the disease caused by the novel coronavirus SARS-CoV-2. The typical presentation is with fever and/or respiratory infection, but some cases may have milder symptoms or be asymptomatic.
People with narcolepsy should have the same risk of getting the disease as the general population.
Based on our current understanding of the condition, people with narcolepsy should not be at increased risk from COVID-19.
The main factors which cause increased risk of serious infection with COVID-19 are
Age >60
Long-term medical condition (e.g. heart disease, high blood pressure, diabetes, chronic lung disease, cancer)
Patients with weak immune system (Immunosuppressed)
The typical medications used for treatment of narcolepsy including wake-promoting agents (such as Modafinil, Ritalin, Concerta, Wakix), medications to treat cataplexy (such as Venlafaxine and Clomipramine) and Xyrem (Sodium Oxybate) do not suppress the immune system and should not cause any increased risk.
However, there is limited information and data available at this time. There is currently no literature on COVID-19 in patients with narcolepsy. We will continue to monitor the situation and update these recommendations if required.
It is recommended to follow the advice from the HSE, regarding hand washing, social distancing, etc.
Updated information is available at this link: https://www.hpsc.ie/a-z/respiratory/coronavirus/novelcoronavirus/
If you have any concerns, please discuss with your medical team.
For the current advice, visit:
www.hse.ie
www.gov.ie/health-covid-19
